Log in
(Ad)
A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

NYSE:HCP - HCP Stock Price, Forecast & News

$36.25
-0.18 (-0.49 %)
(As of 01/22/2020 03:30 AM ET)
Today's Range
$36.09
Now: $36.25
$36.50
50-Day Range
$32.03
MA: $34.15
$36.43
52-Week Range
$26.58
Now: $36.25
$37.93
Volume4.38 million shs
Average Volume2.80 million shs
Market Capitalization$17.80 billion
P/E Ratio19.92
Dividend Yield4.03%
Beta0.22
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustrySpecialized REITs
SectorFinance
CUSIP40414L10
Phone949-407-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.85 billion
Cash Flow$3.40 per share
Book Value$13.70 per share

Profitability

Net Income$1.06 billion

Miscellaneous

Employees201
Market Cap$17.80 billion
Next Earnings Date2/12/2020 (Estimated)
OptionableOptionable

Receive HCP News and Ratings via Email

Sign-up to receive the latest news and ratings for HCP and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

Investors looking for the best way to potentially double their money in 2020 -- regardless of whether the overall markets are up or down -- should look no further than these 3 unique stocks.

This Special Report reveals the names of these stocks and provides everything you need to invest right away.

HCP (NYSE:HCP) Frequently Asked Questions

What is HCP's stock symbol?

HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."

How often does HCP pay dividends? What is the dividend yield for HCP?

HCP announced a quarterly dividend on Wednesday, October 23rd. Investors of record on Monday, November 4th will be paid a dividend of $0.37 per share on Tuesday, November 19th. This represents a $1.48 dividend on an annualized basis and a yield of 4.08%. The ex-dividend date of this dividend is Friday, November 1st. View HCP's Dividend History.

How were HCP's earnings last quarter?

HCP, Inc. (NYSE:HCP) issued its quarterly earnings data on Wednesday, October, 30th. The real estate investment trust reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.43 by $0.52. The real estate investment trust earned $538 million during the quarter, compared to analysts' expectations of $503.65 million. HCP had a net margin of 43.66% and a return on equity of 12.78%. The company's revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.44 EPS. View HCP's Earnings History.

When is HCP's next earnings date?

HCP is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for HCP.

What guidance has HCP issued on next quarter's earnings?

HCP updated its FY19 earnings guidance on Wednesday, October, 30th. The company provided earnings per share guidance of $1.74-1.78 for the period, compared to the Thomson Reuters consensus estimate of $1.75.

What price target have analysts set for HCP?

9 equities research analysts have issued 12 month price targets for HCP's shares. Their forecasts range from $33.00 to $39.00. On average, they anticipate HCP's stock price to reach $36.50 in the next twelve months. This suggests a possible upside of 0.7% from the stock's current price. View Analyst Price Targets for HCP.

What is the consensus analysts' recommendation for HCP?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCP in the last year. There are currently 1 hold rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for HCP.

Has HCP been receiving favorable news coverage?

Headlines about HCP stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. HCP earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news headlines about the real estate investment trust a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for HCP.

Who are some of HCP's key competitors?

What other stocks do shareholders of HCP own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HCP investors own include AT&T (T), Welltower (WELL), Omega Healthcare Investors (OHI), AbbVie (ABBV), Realty Income (O), Verizon Communications (VZ), Cisco Systems (CSCO), Intel (INTC), Walt Disney (DIS) and Johnson & Johnson (JNJ).

Who are HCP's key executives?

HCP's management team includes the folowing people:
  • Mr. Thomas M. Herzog, Pres, CEO & Director (Age 56)
  • Mr. Peter A. Scott, Exec. VP & CFO (Age 39)
  • Mr. Thomas M. Klaritch, Exec. VP, COO & Chief Devel. Officer (Age 61)
  • Mr. Scott M. Brinker, Exec. VP & Chief Investment Officer (Age 42)
  • Mr. Troy E. McHenry, Exec. VP, Gen. Counsel & Corp. Sec. (Age 46)

Who are HCP's major shareholders?

HCP's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Aurora Investment Managers LLC. (0.00%). Company insiders that own HCP stock include Christine Garvey, Kendall K Young, R Kent Griffin Jr and Thomas Klaritch. View Institutional Ownership Trends for HCP.

Which institutional investors are buying HCP stock?

HCP stock was bought by a variety of institutional investors in the last quarter, including Aurora Investment Managers LLC.. Company insiders that have bought HCP stock in the last two years include Kendall K Young and R Kent Griffin Jr. View Insider Buying and Selling for HCP.

How do I buy shares of HCP?

Shares of HCP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is HCP's stock price today?

One share of HCP stock can currently be purchased for approximately $36.25.

How big of a company is HCP?

HCP has a market capitalization of $17.80 billion and generates $1.85 billion in revenue each year. The real estate investment trust earns $1.06 billion in net income (profit) each year or $1.82 on an earnings per share basis. HCP employs 201 workers across the globe.View Additional Information About HCP.

What is HCP's official website?

The official website for HCP is http://www.hcpi.com/.

How can I contact HCP?

HCP's mailing address is 1920 MAIN STREET SUITE 1200, IRVINE CA, 92614. The real estate investment trust can be reached via phone at 949-407-0700 or via email at [email protected]


MarketBeat Community Rating for HCP (NYSE HCP)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  508 (Vote Outperform)
Underperform Votes:  841 (Vote Underperform)
Total Votes:  1,349
MarketBeat's community ratings are surveys of what our community members think about HCP and other stocks. Vote "Outperform" if you believe HCP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel